A Systematic Review of the Clinical Efficacy of Treatments in Relapsed or Refractory Diffuse Large B Cell Lymphoma

INTRODUCTION: Novel treatment options are needed to improve outcomes in transplant-ineligible relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL). This systematic literature review evaluated clinical evidence on treatments for patients with R/R DLBCL ineligible for, or relapsed following...

Descripción completa

Detalles Bibliográficos
Autores principales: Thuresson, Per-Olof, Vander Velde, Nancy, Gupta, Palvi, Talbot, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595978/
https://www.ncbi.nlm.nih.gov/pubmed/33001384
http://dx.doi.org/10.1007/s12325-020-01507-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595978/
https://www.ncbi.nlm.nih.gov/pubmed/33001384
http://dx.doi.org/10.1007/s12325-020-01507-7

Ejemplares similares